spacer
spacer

PDBsum entry 2p94

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase PDB id
2p94

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
234 a.a. *
52 a.a. *
Ligands
ME4
Waters ×135
* Residue conservation analysis
PDB id:
2p94
Name: Hydrolase
Title: Factor xa in complex with the inhibitor 3-chloro-n-((1r,2s)-2-(4-(2- oxopyridin-1(2h)-yl)benzamido)cyclohexyl)-1h-indole-6-carboxamide
Structure: Factor xa. Chain: a. Fragment: residues 16-244. Synonym: factor xa heavy chain, activated factor xa heavy chain. Factor xa. Chain: l. Fragment: residues 87-138. Synonym: factor xa light chain. Ec: 3.4.21.6
Source: Homo sapiens. Human. Organism_taxid: 9606. Organism_taxid: 9606
Resolution:
1.80Å     R-factor:   0.297     R-free:   0.330
Authors: C.-H.Chang
Key ref: J.X.Qiao et al. (2007). SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa. Bioorg Med Chem Lett, 17, 4419-4427. PubMed id: 17588746 DOI: 10.1016/j.bmcl.2007.06.029
Date:
23-Mar-07     Release date:   24-Jul-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00742  (FA10_HUMAN) -  Coagulation factor X from Homo sapiens
Seq:
Struc:
488 a.a.
234 a.a.
Protein chain
Pfam   ArchSchema ?
P00742  (FA10_HUMAN) -  Coagulation factor X from Homo sapiens
Seq:
Struc:
488 a.a.
52 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chains A, L: E.C.3.4.21.6  - coagulation factor Xa.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Preferential cleavage: Arg-|-Thr and then Arg-|-Ile bonds in prothrombin to form thrombin.

 

 
DOI no: 10.1016/j.bmcl.2007.06.029 Bioorg Med Chem Lett 17:4419-4427 (2007)
PubMed id: 17588746  
 
 
SAR and X-ray structures of enantiopure 1,2-cis-(1R,2S)-cyclopentyldiamine and cyclohexyldiamine derivatives as inhibitors of coagulation Factor Xa.
J.X.Qiao, C.H.Chang, D.L.Cheney, P.E.Morin, G.Z.Wang, S.R.King, T.C.Wang, A.R.Rendina, J.M.Luettgen, R.M.Knabb, R.R.Wexler, P.Y.Lam.
 
  ABSTRACT  
 
In the search of Factor Xa (FXa) inhibitors structurally different from the pyrazole-based series, we identified a viable series of enantiopure cis-(1R,2S)-cycloalkyldiamine derivatives as potent and selective inhibitors of FXa. Among them, cyclohexyldiamide 7 and cyclopentyldiamide 9 were the most potent neutral compounds, and had good anticoagulant activity comparable to the pyrazole-based analogs. Crystal structures of 7-FXa and 9-FXa illustrate binding similarities and differences between the five- and the six-membered core systems, and provide rationales for the observed SAR of P1 and linker moieties.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
19967784 Y.K.Lee, and M.R.Player (2011).
Developments in factor Xa inhibitors for the treatment of thromboembolic disorders.
  Med Res Rev, 31, 202-283.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer